Cited by 23Cervical Cancer and HPV ResearchWomen's cancer prevention and managementReproductive tract infections research

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Human papillomavirus (HPV) testing on self-collected specimens: perceptions among HIV positive women attending rural and urban clinics in South Africa

Open access

Abstract

INTRODUCTION: Cervical cancer is the most common cancer among women in Sub-Saharan Africa. Cervical cancer is treatable if detected timeously, yet only 20% of South African women have ever been for a Pap smear in their lifetime due to limited access to screening, transport or child care responsibilities. OBJECTIVE: To evaluate the acceptability of self-collection for cervical cancer screening. We aimed to identify which self-collection device women prefer and if they would consider using them for routine cervical cancer screening. METHODS: HIV-positive women (>18 years) from urban and rural HIV clinics were interviewed following an education session on HIV, human papillomavirus (HPV) and cervical cancer. Participants were shown three self-collection devices; (i) an Evalyn cervical brush, (ii) a Delphilavager and (iii) a tampon-like plastic wand before completing a short questionnaire. RESULTS: A total of 106 women from the urban (n = 52) and rural (n = 54) clinic were interviewed. Overall 51% of women preferred the cervical brush, while fewer women preferred the tampon-like plastic wand (31%) or lavage sampler (18%). More than 75% of women from the rural site preferred the cervical brush, compared to 22% from the urban site (p < 0.001). Women from the urban clinic preferred the tampon-like plastic wand (45%) and then the lavage sampler (33%), as compared to women from the rural clinic (19% and 4%, respectively). CONCLUSION: Women from urban or rural settings had different preferences for the various self-collection devices. Patient self-collection with HPV testing may be an acceptable way to improve coverage to cervical cancer screening in high risk HIV-seropositive women.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.11604/pamj.2014.17.189.3454

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 30

  1. [1]Ferlay J Bray F Pisani P Parkin DM GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide IARC Cancer Base No.5 2004 Lyon IARC Press version 2.0.
  2. [2]Parkin DM Sitas F Chirenje M Stein L Abratt R Wabinga H Part I: Cancer in Indigenous Africans-burden, distribution, and trends Lancet Oncol. 2008 9 7 683 92 18598933
  3. [3]Denny L Quinn M Sankaranarayanan R Chapter 8: Screening for cervical cancer in developing countries Vaccine 2006 24 Suppl 3 S71 77 16950020
  4. [4]Faridi R Zahra A Khan K Idrees M Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer Virol. 2011 8 269 PMC3118362 21635792
  5. [5]Smith JS Lindsay L Hoots B Keys J Franceschi S Winer R Clifford GM Human papillomavirus typedistribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update Int J Cancer. 2007 121 3 621 632 17405118
  6. [6]Denny L Adewole I Anorlu R Dreyer G Moodley M Smith T Snyman L Wiredu E Molijn A Quint W Ramakrishnan G Schmidt J Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa Int J Cancer. 2013 134 6 1389 98 23929250
  7. [7]Koshiol J Lindsay L Pimenta JM Poole C Jenkins D Smith JS Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis Am J Epidemiol. 2008 168 2 123 137 18483125 PMC2878094
  8. [8]Cu-Uvin S Hogan JW Warren D Klein RS Peipert J Schuman P Holmberg S Anderson J Schoenbaum E Vlahov D Mayer KH for the HIV Epidemiology Research Study Group Prevalence of Lower Genital Tract Infections among Human Immunodeficiency Virus (HIV)-Seropositive and High-Risk HIV-Seronegative Women Clin Infect Dis 1999 29 5 1145 50 10524955
  9. [9]Firnhaber C Mayisela N Mao L Williams S Swarts A Faesen M Levin S Michelow P Omar T Hudgens MG Williamson AL Allan B Lewis DA Smith JS Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa PLoS One. 2013 8 1 53494 PMC3543403 23326441
  10. [10]Lomalisa P Smith T Guidozzi F Human immunodeficiency virus infection and invasive cervical cancer in South Africa GynecolOncol. 2000 77 3 460 463 10831360
  11. [11]Cronjé HS Cervical screening strategies in resourced and resource-constrained countries Best Pract Res Clin Obstet Gynaecol. 2011 25 5 575 84 21689987
  12. [12]Belinson JL Qiao YL Pretorius RG Zhang WH Rong SD Huang MN Zhao FH Wu LY Ren SD Huang RD Washington MF Pan QJ Li L Fife D Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology Int J Gynecol Cancer. 2003 13 6 819 26 14675319
  13. [13]Richman AR Brewer NT Liebman AK Rinas AC Smith JS Optimising human papillomavirus self-testing for high risk women Sex Transm Infect. 2011 87 2 118 122 21115503
  14. [14]Scarinci IC Litton AG Garcés-Palacio IC Partridge EE Castle PE Acceptability and usability of self-collected sampling for HPV testing among African-American women living in the Mississippi Delta Womens Health Issues. 2013 23 2 123 30 PMC3596478 23410619
  15. [15]Arriba LN Enerson CL Belinson S Novick L Belinson J Mexican Cervical Cancer Screening Study II: acceptability of human papillomavirus self-sampler Int J Gynecol Cancer. 2010 20 8 1415 23 21051987
  16. [16]Firnhaber C Zungu K Levin S Michelow P Montaner LJ McPhail P Williamson AL Allan BR Van der Horst C Rinas A Sanne I Diverse and high prevalence of human papillomavirus associated with a significant high rate of cervical dysplasia in human immunodeficiency virus-infected women in Johannesburg, South Africa ActaCytol. 2009 53 1 10 7 PMC2922752 19248549
  17. [18]Coutlée F Hankins C Lapointe N Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction - The Canadian Women's HIV Study Group J Med Virol. 1997 51 1 42 47 8986948
  18. [19]Flores Y Shah K Lazcano E Hernandez M Bishai D Ferris DG Lorincz A Hernandez P Salmeron J Morelos HPV study collaborators. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: the Morelos HPV study SaludPublica Mex. 2002 44 4 335 244 12216521
  19. [20]Zhao FH Lewkowitz AK Chen F Lin MJ Hu SY Zhang X Pan QJ Ma JF Niyazi M Li CQ Li SM Smith JS Belinson JL Qiao YL Castle PE Pooled Analysis of a Self-Sampling HPV DNA Test as a Cervical Cancer Primary Screening Method J Natl Cancer Inst. 2012 104 3 178 88 22271765 PMC3274511
  20. [21]Lazcano-Ponce E Lorincz AT Cruz-Valdez A Salmerón J Uribe P Velasco-Mondragón E Nevarez PH Acosta RD Hernández-Avila M Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial Lancet. 2011 378 9806 1868 73 22051739
  21. [23]Sankaranarayanan R Nene BM Shastri SS Jayant K Muwonge R Budukh AM Hingmire S Malvi SG Thorat R Kothari A Chinoy R Kelkar R Kane S Desai S Keskar VR Rajeshwarkar R Panse N Dinshaw KA HPV screening for cervical cancer in rural India N Engl J Med. 2009 360 14 1385 1394 19339719
  22. [24]Lack N West B Jeffries D Ekpo G Morison L Soutter WP Walraven G Boryseiwicz L Comparison of non-invasivesamplingmethods for detection of HPV in rural African women Sex Transm Infect. 2005 81 3 239 41 15923294 PMC1744971
  23. [25]Sahasrabuddhe VV Mwanahamuntu MH Vermund SH Huh WK Lyon MD Stringer JS Parham GP Prevalence and distribution of HOV genotypes among HIV-infected women in Zambia Br J Cancer. 2007 96 9 1480 1483 17437020 PMC2360194
  24. [26]Firnhaber C Van Le H Pettifor A Schulze D Michelow P Sanne I Lewis DA Williamson AL Allan B Williams S Rinas A Levin S Smith JS Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa Cancer Causes Control. 2010 21 3 433 443 19949850 PMC2835728
  25. [27]Suba EJ González-Mena LE Arrecillas-Zamora MD Raab SS Self-collection of vaginal specimens for HPV testing Lancet. 2012 379 9826 1587 8 22541576
  26. [28]Mitchell S Ogilvie G Steinberg M Sekikubo M Biryabarema C Money D Assessing women's willingness to collect their own cervical samples for HPV testing as part of the ASPIRE cervical cancer screening project in Uganda Int J GynaecolObstet 2011 114 2 111 5 21669428
  27. [30]Denny L Cytological screening for cervical cancer prevention Best Pract Res ClinObstetGynaecol. 2012 26 2 189 96 22071306
  28. [31]Snijders PJ Verhoef VM Arbyn M Ogilvie G Minozzi S Banzi R van Kemenade FJ Heideman DA Meijer CJ High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening Int J Cancer. 2013 132 10 2223 36 22907569
  29. [32]Sancho-Garnier H Tamalet C Halfon P Leandri FX Retraite LL Djoufelkit K Heid P Davies P Piana L HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France Int J Cancer. 2013 133 11 2681 2687 23712523
  30. [33]Leyden WA Manos MM Geiger AM Wienmann S Mouchawar J Bischoff K Yood MU Gilbert J Taplin SH Cervical cancer in women with comprehensive health care access: attributable factors in the screening process J Natl Cancer Institute. 2005 97 9 675 683 15870438

Cited by

Sorted by citations

Metadata

Authors
Mahomed, K., Evans, D., Sauls, C., Richter, K., Smith, J., & Firnhaber, C.
Affiliations
  • Right to Care (ZA)
  • University of the Witwatersrand (ZA)
  • National Health Laboratory Service (ZA)
  • University of North Carolina at Chapel Hill (US)
Corresponding author
Mahomed, Kay
Venue
Pan African Medical Journal
Published
2014
Volume
17
Pages
189-189
ISSN
1937-8688 (ISSN-L)
OpenAlex
W2001269929
Cited by
23
References
3
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 2 · 2019: 1 · 2018: 4 · 2016: 2 · 2015: 1
FWCI
0.76
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Pan African Medical Journal (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UpSpace Institutional Repository (University of Pretoria) (submittedVersion, cc-by)
Funders
U.S. President’s Emergency Plan for AIDS Relief
Topics
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
Keywords
HPV testing, self-collected samples, cervical cancer screening, women living with HIV, urban-rural differences, screening acceptability, South Africa
MeSH terms
Adult, Attitude to Health, Uterine Cervical Neoplasms, Female, HIV Seropositivity, Humans, Middle Aged, Surveys and Questionnaires, South Africa, Specimen Handling, Rural Health Services, Urban Health Services, Papillomaviridae, Early Detection of Cancer, Patient Preference, Diagnostic Self Evaluation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review